| Serial Number | 79395718 |
| Word Mark | ABBIL1TY |
| Filing Date | Thursday, February 15, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, August 26, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Pseudo Mark | ABILITY |
| Pseudo Mark | ABBIL ONE TY |
| Goods and Services | Medical and pharmacological research services; clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; all of the aforementioned within the area of antibody therapeutics. |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 16, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Genmab A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 98 - Unknown |
| Address | DK |
| Event Date | Event Description |
| Thursday, May 16, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, May 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 20, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, August 26, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, August 26, 2024 | REFUSAL PROCESSED BY MPU |
| Thursday, May 23, 2024 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, August 13, 2024 | ASSIGNED TO EXAMINER |
| Monday, August 19, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, September 14, 2024 | REFUSAL PROCESSED BY IB |